| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.063 | 0.2 |